Fatal serotonin syndrome: a systematic review of 56 cases in the literature

References

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112–1120.
   PubMed Web of Science ®Google Scholar
• Insel TR, Roy BF, Cohen RM, et al. Possible development of the serotonin syndrome in man. Am J Psychiatry. 1982;139(7):954–955.
   PubMed Web of Science ®Google Scholar
• Sternbach H. The serotonin syndrome. Am J Psychiatry. 1991;148(6):705–713.
   PubMed Web of Science ®Google Scholar
• Attar-Herzberg D, Apel A, Gang N, et al. The serotonin syndrome: initial misdiagnosis. Isr Med Assoc J. 2009;11(6):367–370.
   PubMed Web of Science ®Google Scholar
• Dunkley EJ, Isbister GK, Sibbritt D, et al. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003;96(9):635–642.
   PubMed Web of Science ®Google Scholar
• Kline SS, Mauro LS, Scala-Barnett DM, et al. Serotonin syndrome versus neuroleptic malignant syndrome as a cause of death. Clin Pharm. 1989;8(7):510–514.
   PubMedGoogle Scholar
• Neuvonen P, Pohjola-Sintonen S, Tacke U, et al. Five fatal cases of serotonin syndrome after moclobemide–citalopram or moclobemide–clomipramine overdoses. Lancet. 1993;342(8884):1419.
   PubMed Web of Science ®Google Scholar
• Keltner N, Harris CP. Serotonin syndrome: a case of fatal SSRI/MAOI interaction. Perspect Psychiatr Care. 1994;30(4):26–31.
   PubMed Web of Science ®Google Scholar
• Power BM, Pinder M, Hackett LP, et al. Fatal serotonin syndrome following a combined overdose of moclobemide, clomipramine and fluoxetine. Anaesth Intensive Care. 1995;23(4):499–502.
   PubMed Web of Science ®Google Scholar
• Kuisma MJ. Fatal serotonin syndrome with trismus. Ann Emerg Med. 1995;26(1):108.
   PubMed Web of Science ®Google Scholar
• van Berkum MM, Thiel JM, Leikin JB, et al. A fatality due to serotonin syndrome. Med Update Psychiatr. 1997;2(2):55–57.
   Google Scholar
• Mclntyre IM, King CV, Staikos V, et al. A fatality involving moclobemide, sertraline, and pimozide. J Forensic Sci. 1997;42(5):951–953.
   PubMed Web of Science ®Google Scholar
• Singer PP, Jones GR. An uncommon fatality due to moclobemide and paroxetine. J Anal Toxicol. 1997;21(6):518–520.
   PubMed Web of Science ®Google Scholar
• Mueller PD, Korey WS. Death by “ecstasy”: the serotonin syndrome? Ann Emerg Med. 1998;32(3 Pt 1):377–380.
   PubMed Web of Science ®Google Scholar
• Ferrer-Dufol A, Perez-Aradros C, Murillo EC, et al. Fatal serotonin syndrome caused by moclobemide–clomipramine overdose. J Toxicol Clin Toxicol. 1998;36(1–2):31–32.
   PubMed Web of Science ®Google Scholar
• Mackay FJ, Dunn NR, Mann RD. Antidepressants and the serotonin syndrome in general practice. Br J Gen Pract. 1999;49(448):871–874.
   PubMed Web of Science ®Google Scholar
• Rogde S, Hilberg T, Teige B. Fatal combined intoxication with new antidepressants. Human cases and an experimental study of postmortem moclobemide redistribution. Forensic Sci Int. 1999;100(1–2):109–116.
   PubMed Web of Science ®Google Scholar
• Avarello TP, Cottone S. Serotonin syndrome: a reported case. Neurol Sci. 2002;23:S55–S56.
   PubMed Web of Science ®Google Scholar
• Karki SD, Masood GR. Combination risperidone and SSRI-induced serotonin syndrome. Ann Pharmacother. 2003;37(3):388–391.
   PubMed Web of Science ®Google Scholar
• Vuori E, Henry JA, Ojanperä I, et al. Death following ingestion of MDMA (ecstasy) and moclobemide. Addiction. 2003;98(3):365–368.
   PubMed Web of Science ®Google Scholar
• Otte W, Birkenhager TK, van den Broek WW. Fatal interaction between tranylcypromine and imipramine. Eur Psychiatry. 2003;18(5):264–265.
   PubMed Web of Science ®Google Scholar
• Lam F. Serotonin syndrome and death, possibly caused by moclobemide, sertraline and pimozide interaction. Brown Univ Psychopharmacol Update. 2003;14(5):2.
   Google Scholar
• Hachem RY, Hicks K, Huen A, et al. Myelosuppression and serotonin syndrome associated with concurrent use of linezolid and selective serotonin reuptake inhibitors in bone marrow transplant recipients. Clin Infect Dis. 2003;37(1):e8.
   PubMed Web of Science ®Google Scholar
• Bernard L, Stern R, Lew D, et al. Serotonin syndrome after concomitant treatment with linezolid and citalopram. Clin Infect Dis. 2003;36(9):1197.
   PubMed Web of Science ®Google Scholar
• House CJ, Zebrowska G. Death following moclobemide and venlafaxine overdose. Can Soc Forensic Sci J. 2005;38(1):25–33.
   Google Scholar
• Sener S, Yamanel L, Comert B. A fatal case of severe serotonin syndrome accompanied by moclobemide and paroxetine overdose. Indian J Crit Care Med. 2005;9(3):173–175.
   Google Scholar
• Clark DB, Andrus MR, Byrd DC. Drug interactions between linezolid and selective serotonin reuptake inhibitors: case report involving sertraline and review of the literature. Pharmacotherapy. 2006; 26(2):269–276.
   PubMed Web of Science ®Google Scholar
• Gómez-Esteban JC, Barcena J, Forcadas M, et al. Neuroleptic malignant syndrome and serotonin syndrome in a female patient: a clinicopathologic case. Clin Neuropharmacol. 2009;32(5):299–300.
   PubMed Web of Science ®Google Scholar
• Pilgrim JL, Gerostamoulos D, Drummer OH. Deaths involving serotonergic drugs. Forensic Sci Int. 2010;198(1–3):110–117.
   PubMed Web of Science ®Google Scholar
• Pilgrim JL, Gerostamoulos D, Woodford N, et al. Serotonin toxicity involving MDMA (ecstasy) and moclobemide. Forensic Sci Int. 2012;215(1–3):184–188.
   PubMed Web of Science ®Google Scholar
• Kłys M, Kowalski P, Rojek S, et al. Death of a female cocaine user due to the serotonin syndrome following moclobemide–venlafaxine overdose. Forensic Sci Int. 2009;184(1–3):e16–e20.
   PubMed Web of Science ®Google Scholar
• Muzyk AJ, Jakel RJ, Preud'homme X. Serotonin syndrome after a massive overdose of controlled-release paroxetine. Psychosomatics. 2010;51(5):437–442.
   PubMed Web of Science ®Google Scholar
• Degner D, Porzig J, Rüther E, et al. Serotonin syndrome with severe hyperthermia after ingestion of tranylcypromine combined with serotonin reuptake inhibitors and tyramine-rich food in a case of suicide. Pharmacopsychiatry. 2010;43(7):284–285.
   PubMed Web of Science ®Google Scholar
• Slettedal JK, Nilssen DO, Magelssen M, et al. Brain pathology in fatal serotonin syndrome: presentation of two cases. Neuropathology. 2011;31(3):265–270.
   PubMed Web of Science ®Google Scholar
• Wu ML, Deng JF. Fatal serotonin toxicity caused by moclobemide and fluoxetine overdose. Chang Gung Med J. 2011;34(6):644–649.
   PubMedGoogle Scholar
• Dardis C, Omoregie E, Ly V. Fatal serotonin syndrome precipitated by oxcarbazepine in a patient using an selective serotonin reuptake inhibitor. Neurologist. 2012;18(4):204–205.
   PubMed Web of Science ®Google Scholar
• Warrick BJ, Wilson J, Hedge M, et al. Lethal serotonin syndrome after methylone and butylone ingestion. J Med Toxicol. 2012;8(1):65–68.
   PubMedGoogle Scholar
• John S, Donnelly M, Uchino K. Catastrophic reversible cerebral vasoconstriction syndrome associated with serotonin syndrome. Headache. 2013;53(9):1482–1487.
   PubMed Web of Science ®Google Scholar
• Batista M, Dugernier T, Simon M, et al. The spectrum of acute heart failure after venlafaxine overdose. Clin Toxicol. 2013;51(2):92–95.
   Web of Science ®Google Scholar
• Choudhry ME. Serotonin syndrome and acute hyponatremia, complex overlapping syndromes, a case report and review. Case Rep Clin Med. 2014;3(2):92–96.
   Google Scholar
• Top WM, Gillman PK, De Langen CJ, et al. Fatal methylene blue associated serotonin toxicity. Neth J Med. 2014;72(3):179–181.
   PubMed Web of Science ®Google Scholar
• Yoshida KI, Saka K, Shintani-Ishida K, et al. A case of fatal intoxication due to the new designer drug 25B-NBOMe. Forensic Toxicol. 2015;33(2):396–401.
   Web of Science ®Google Scholar
• Andreasen MF, Telving R, Rosendal I, et al. A fatal poisoning involving 25C-NBOMe. Forensic Sci Int. 2015;251:e1–e8.
   PubMed Web of Science ®Google Scholar
• Kraai EP, Seifert SA. Citalopram overdose: a fatal case. J Med Toxicol. 2015;11(2):232–236.
   PubMed Web of Science ®Google Scholar
• Koekkoek WA, Tjan DH. The serotonin syndrome – a narrative review. Netherlands J Crit Care. 2017;9:94–98.
   Google Scholar
• Alghamdi S, Seddeq Y, Algahtani H, et al. Fatal serotonin syndrome in a patient with Marchiafava-Bignami disease: combined neurological and psychiatric emergency. Neurol Neurochir Pol. 2018;52(2):277–280.
   PubMed Web of Science ®Google Scholar
• Trungu J, Laarbaui F, Dechamps M, et al. Rapidly fatal neurological and cardiocirculatory failure in a patient recently treated with nefopam. Minerva Anestesiol. 2019;85(5):561–562.
   PubMed Web of Science ®Google Scholar
• Harmouche E, Olano JD, Mashlah A, et al. Fatal metaxalone-induced serotonin toxicity. Clin Toxicol. 2019;57(6):151–152.
   Web of Science ®Google Scholar
• Troya J, Martínez de Gándara A, Ryan P, et al. Mephedrone and chemsex: when it stops being a party and becomes a fatal problem. Int J STD Aids. 2019;30(10):1028–1030.
   PubMed Web of Science ®Google Scholar
• Alibegović A, Kariž S, Volavšek M. Fatal overdose with a combination of SNRIs venlafaxine and duloxetine. Forensic Sci Med Pathol. 2019;15(2):258–261.
   PubMed Web of Science ®Google Scholar
• Ott M, Mannchen JK, Jamshidi F, et al. Management of severe arterial hypertension associated with serotonin syndrome: a case report analysis based on systematic review techniques. Ther Adv Psychopharmacol. 2019;9:2045125318818814.
   Web of Science ®Google Scholar
• Elsayed YM. Tramadol-induced hypertensive crises, acute pulmonary edema, serotonin syndrome, and death in the beggar abused patient; a case report. Med Read J Addict Sci. 2020;1:id1002.
   Google Scholar
• Abadie D, Rousseau V, Logerot S, et al. Serotonin syndrome: analysis of cases registered in the French pharmacovigilance database. J Clin Psychopharmacol. 2015;35(4):382–388.
   PubMed Web of Science ®Google Scholar
• Nguyen H, Pan A, Smollin C, et al. An 11-year retrospective review of cyproheptadine use in serotonin syndrome cases reported to the California Poison Control System. J Clin Pharm Ther. 2019;44(2):327–334.
   PubMed Web of Science ®Google Scholar
• Gummin DD, Mowry JB, Spyker DA, et al. 2018 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 36th annual report. Clin Toxicol. 2019;57(12):1220–1413.
   PubMed Web of Science ®Google Scholar
• Perry PJ, Wilborn CA. Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management. Ann Clin Psychiatry. 2012;24(2):155–162.
   PubMed Web of Science ®Google Scholar
• Prakash S, Rathore C, Rana KK, et al. Refining the clinical features of serotonin syndrome: a prospective observational study of 45 patients. Ann Indian Acad Neurol. 2019;22(1):52–60.
   PubMed Web of Science ®Google Scholar
• Bartakke A, Corredor C, van Rensburg A. Serotonin syndrome in the perioperative period. BJA Educ. 2020;20(1):10–17.
   PubMed Web of Science ®Google Scholar
• Buckley NA, Dawson AH, Isbister GK. Serotonin syndrome. BMJ. 2014;348:g1626.
   PubMed Web of Science ®Google Scholar
• Davis JJ, Buck NS, Swenson JD, et al. Serotonin syndrome manifesting as patient movement during total intravenous anesthesia with propofol and remifentanil. J Clin Anesth. 2013;25(1):52–54.
   PubMed Web of Science ®Google Scholar
• Mason PJ, Morris VA, Balcezak TJ. Serotonin syndrome. Presentation of 2 cases and review of the literature. Medicine (Baltimore). 2000;79(4):201–209.
   PubMed Web of Science ®Google Scholar
• Werneke U, Jamshidi F, Taylor DM, et al. Conundrums in neurology: diagnosing serotonin syndrome – a meta-analysis of cases. BMC Neurol. 2016;16(1):97.
   PubMed Web of Science ®Google Scholar
• Prakash S, Rathore C, Rana K. Knowledge, attitude, and practice (KAP) study on serotonin syndrome among neuro physicians. Ann Indian Acad Neurol. 2020. DOI:10.4103/aian.AIAN_603_19.
   PubMed Web of Science ®Google Scholar
• Mills KC. Serotonin syndrome. A clinical update. Crit Care Clin. 1997;13(4):763–783.
   PubMed Web of Science ®Google Scholar
• Graudins A, Stearman A, Chan B. Treatment of the serotonin syndrome with cyproheptadine. J Emerg Med. 1998;16(4):615–619.
   PubMedGoogle Scholar
• Gillman PK. The serotonin syndrome and its treatment. J Psychopharmacol. 1999;13(1):100–109.
   PubMed Web of Science ®Google Scholar